Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Medicines Called Dysport(R) (Atc: M03ax21)

Medicines with the Active Ingredient Raltegravir (Atc: J05aj01)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Dimethyl Fumarate, Atc D05bx01 for the Period January 1St, 2024 - December 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Buserelin, Atc L02ae01 for the Period January 1St, 2024 - December 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Insulin Lispro, Atc A10ab04, A10ad04 F. D. Time 01/01/24 - 12/31/24 (Plus Extension Option 1X12 Months)

Market Consultation Co2 Laser for Ent

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Formoterol Beclometasone (Exclusively Dafo. Dos), Atc R03ak08 for the Period January 1St, 2024 - December 31St, 2025

Open House Drug Discount Agreements Tocilizumab, Atc L04ac07

Open House Drug Discount Contracts Testosterone, Atc G03ba03

Framework Agreement for the Supply of Active Dressings and Wound Care Materials